Education
About Us
Working with TipRanks
Follow Us
Regen Biopharma (RGBP)
OTHER OTC:RGBP
RGBP Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.02 - $0.60
Previous CloseN/A
Volume4.72K
Average Volume (3M)17.16K
Market Cap
$948.41K
Enterprise Value$3.28M
Total Cash (Recent Filing)$135.00
Total Debt (Recent Filing)$873.14K
Price to Earnings (P/E)―
Beta-0.01
Next EarningsN/A
EPS EstimateN/A
Last Dividend Ex-Date
Jul 05, 2024Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding21,554,705
10 Day Avg. Volume26,446
30 Day Avg. Volume17,164
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-0.10
Price to Sales (P/S)0.00
P/FCF Ratio-2.36
Enterprise Value/Market Cap3.46
Enterprise Value/Revenue3.47
Enterprise Value/Gross Profit32.49
Enterprise Value/Ebitda-1.32
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Regen Biopharma News
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
RGBP FAQ
What was Regen Biopharma’s price range in the past 12 months?
Regen Biopharma lowest stock price was $0.02 and its highest was $0.60 in the past 12 months.
What is Regen Biopharma’s market cap?
Regen Biopharma’s market cap is $948.41K.
When is Regen Biopharma’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Regen Biopharma’s earnings last quarter?
Regen Biopharma released its earnings results on May 14, 2018. The company reported -$0.008 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.008.
Is Regen Biopharma overvalued?
According to Wall Street analysts Regen Biopharma’s price is currently Overvalued.
Does Regen Biopharma pay dividends?
Regen Biopharma pays a Notavailable dividend of $0.057 which represents an annual dividend yield of N/A. See more information on Regen Biopharma dividends here
What is Regen Biopharma’s EPS estimate?
Regen Biopharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Regen Biopharma have?
Regen Biopharma has 21,554,705 shares outstanding.
What happened to Regen Biopharma’s price movement after its last earnings report?
Regen Biopharma reported an EPS of -$0.008 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Regen Biopharma?
Currently, no hedge funds are holding shares in RGBP
Company Description
Regen Biopharma
Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It engages in actively identifying small molecules that inhibit or express NR2F6 leading to immune cell activation for oncology applications, and immune cell suppression for autoimmune disease. The company is in the early stages of development of its products, and therapies. Regen BioPharma, Inc. was incorporated in 2012 and is based in La Mesa, California.
Technical Analysis
Hepion Pharmaceuticals
―
Windtree Therapeutics
―
LogicMark
―
Revelation Biosciences
―
Universe Pharmaceuticals
―